Top compounds associated with response to A2M


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.054 0.2
mRNA tivozanib CTRPv2 pan-cancer AAC 0.012 0.8
mRNA tivozanib GDSC1000 pan-cancer AAC -0.0069 0.9
mRNA tosedostat CTRPv2 pan-cancer AAC -0.0038 0.9
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0074 0.8
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.00064 1
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.061 0.04
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.011 0.8
mRNA triptolide CTRPv2 pan-cancer AAC -0.033 0.4
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.02 0.6
Download CSV